Cardiology Cardiology Hematology - Oncology Hematology - Oncology Immunology Immunology Rare Diseases Rare Diseases
At Biologix, we are fully committed to improving healthcare outcomes for patients, through innovative pharmaceuticals and market access solutions.

Rare diseases affect millions of people worldwide therefore, we strive to make a meaningful impact on people’s lives because we believe that access to the best possible treatment is the right of every person suffering from a rare disease.

For this purpose, Biologix Rare Disease franchise works closely with specialists, healthcare professionals, and medical/ patient associations to spread knowledge, improve diagnosis and management, and enable access to treatment by supporting patients. 

Biologix has a vast experience in bringing to market biotech drugs for rare diseases, with a portfolio of 10 products in the MENA region. We aspire to help the Rare Disease community through different patient support programs focusing on optimizing standards of care beyond just the treatment. Biologix expertise in rare diseases is centered around the nephrology, neuro-ophthalmology, hematology, neuromuscular and endo metabolic fields.


  • Increlex
  • Lamzede
  • Procysbi
  • Radicava
  • Raxone
  • Ztalmy
Rare Diseases patients

Our Rare Disease line is currently treating more than 450 patients.

Rare Diseases counties

Our RD products cover 12 countries and treat 14 different rare diseases.